Tiny Corbus looks to take on Vertex with experimental lung drug
May 04, 2015 at 17:40 PM EDT
May 4 (Reuters) - Corbus Pharmaceuticals Holdings Inc's experimental drug for cystic fibrosis, a rare lung-scarring disease, could be a real money spinner and pose a challenge to rival Vertex Pharmaceuticals Inc's successful treatment, Kalydeco.
